In lung cancer and glioblastoma, a GRP78 antibody enhanced radiosensitivity by upregulation of apoptosis in vitro and the combined antibody/radiation treatment was the most effective treatment for in vivo models for both tumor types (44). This evidence concerns the gene HSPA5 and lung carcinoma.